Inactive Instrument

News Plasmatech Biopharmaceuticals Inc Nasdaq

Stocks

US72754H1095

Pharmaceuticals

End-of-day quote Nasdaq
- ^USD	-

08-14	Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating	MT
08-13	Abeona Therapeutics Shares Fall After Q2 Miss	MT

All News

Mentions Relevance

08-14	Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating	MT
08-13	Abeona Therapeutics Shares Fall After Q2 Miss	MT
08-13	Abeona Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026
08-13	Abeona Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-13	Abeona Therapeutics: Q2 Earnings Snapshot	AQ
08-13	Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update	AQ
08-06	Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026	AQ
08-04	Abeona Therapeutics Inc. Grants New Technology Add-On Payment Status For ZEVASKYN	CI
08-04	Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
08-04	CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®	AQ
08-03	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
07-21	Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®	AQ
07-01	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
06-29	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) added to Russell 2000 Value-Defensive Index	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000 Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) added to Russell 2000 Defensive Index	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Microcap Growth Benchmark Index	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Small Cap Comp Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 2500 Growth Benchmark	CI
06-28	Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 2000 Growth Benchmark	CI
06-12	Abeona Therapeutics Inc. Announces Resignation of Michael Amoroso as Member of Board of Directors, Nominating and Corporate Governance Committee, Effective June 11, 2026	CI
06-04	Abeona Therapeutics Inc Participates in Pre-Investigational New Drug Meeting with Fda Regarding Abo-701	CI
06-01	Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
05-26	Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences	AQ